Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31400306)
This publication has 33 references indexed in Scilit:
- Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanesThe Prostate, 2014
- Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathwayToxicology Letters, 2014
- Cisplatin Loaded Methoxy Poly (ethylene glycol)-block -Poly (L -glutamic acid-co -L -Phenylalanine) Nanoparticles against Human Breast Cancer CellMacromolecular Bioscience, 2014
- Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cellsMolecular Cancer, 2014
- Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cellsGastric Cancer, 2012
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic CancerPLOS ONE, 2011
- BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell DeathClinical Cancer Research, 2007
- Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosisNucleic Acids Research, 2005
- Cisplatin: From DNA damage to cancer chemotherapy2001
- Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell lineInternational Journal of Cancer, 1996